NOT-AR-21-026: Notice of NIAMS Withdrawal from Participation inPAR-19-172 "Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)"

Notice of NIAMS Withdrawal from Participation in PAR-19-172 "Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)"

Notice Number:

NOT-AR-21-026

Key Dates

Release Date:

July 23, 2021

Related Announcements

PAR-19-172 - Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

Effective immediately, the NIAMS withdraws its participation in PAR-19-172 "Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)."

Inquiries

Please direct all inquiries to:

Marie Mancini, PhD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-594-5032
Email:Mancinim2@mail.nih.gov